Navigation Links
Par Pharmaceutical Companies Reports Third Quarter 2011 Results
Date:11/2/2011

settlements and contingencies

-2,250Non-cash interest expense

-533Abrika earn-out payment

-(3,567)Sum of adjustments, pre-tax

$2,852$1,216Estimated tax on adjustments

551(462)Domestic manufacturing tax benefit

-(2,009)Adjusted Income from Continuing Operations (non-GAAP measure)

$25,458$29,406Amortization Expense

2,5483,079Estimated tax impact

(943)(1,170)Amortization Expense, net of tax

1,6051,909Adjusted Cash basis from Continuing Operations (non-GAAP measure)27,06331,315"Cash EPS" from Continuing Operations (non-GAAP measure)$0.74$0.88Diluted weighted average shares outstanding

36,77435,684Nine Months EndedSeptember 30,September 30,20112010(Loss) Income from Continuing Operations($77,609)$75,122Litigation settlements and contingencies, pre-tax

190,560(1,880)Restructuring costs

27,660-Transaction costs for Edict and Anchen

2,852-Upfront and development milestone payments

-19,000Sale of product rights

-(5,000)Non-cash interest expense

-1,571Abrika earn-out payment

-(3,567)Sum of adjustments, pre-tax

$221,072$10,124Estimated tax on adjustments

(58,397)(3,847)Charge related to valuation of deferred income tax assets

2,391-Resolution of tax contingencies

-(3,657)Domestic manufacturing tax benefit

-(2,009)Adjusted Income from Continuing Operations (non-GAAP measure)

$87,457$75,733Amortization Expense

8,66611,233Estimated tax impact

(3,238)(4,269)Amortization Expense, net of tax

5,4286,964Adjusted Cash basis from Continuing Operations (non-GAAP measure)92,88582,697"Cash EPS" from Continuing Operations (non-GAAP measure)$2.54$2.34Diluted weighted average shares outstanding

36,52535,410
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vzhr6h/video ) has ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - ... has been the topic of fascination since the era of ... and the Soviet Russia. Earlier even a small glimpse ...
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... using endoscopy to stalk pathology know that sharper ... until now, high-definition endocams have been too expensive ... surgery centers. (Logo: http://photos.prnewswire.com/prnh/20120426/CG95191LOGO ... Corp. changes that with the groundbreaking 5514 Endocam ...
... SAN DIEGO, May 18, 2012  Ocera Therapeutics Inc., ... and commercialization of proprietary agents to treat gastrointestinal ... received a CE Mark for Zysa™ (spherical carbon ... predominant IBS (IBS-d), a condition affecting 10-15% of ...
Cached Medicine Technology:Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD 2Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d) 2Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d) 3
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... N.Y., April 23 MediCepts, Inc. is pleased,to ... as,the first practice in New York State to ... to its neck and back pain,patients. Owned and ... Tony Corso, MS,PT, Corso Rehabilitation and Physical Therapy ...
... April 23 A ruling by Alameda County,Superior ... the,Service Employees International Union and its President Andy ... continued acts of threats,harassment, and stalking of registered ... Tuesday night., "The TRO gave the nurses ...
... Superior court dismisses illegal temporary restraining order ... publicity stunt, OAKLAND, Calif., April 22 ... order against the,Service Employees International Union (SEIU) and ... publicity stunt by the California Nurses Association,(CNA). The ...
... Congressmen Buyer (R-IN) and Jim Matheson (D-UT) ... chain., ALEXANDRIA, Va., April 22 ... association,representing medical products distributors since 1902, applauds ... for introducing the bipartisan,H.R. 5839, the Safeguarding ...
... 22 drugstore.com, inc.,(Nasdaq: DSCM ), a ... products, will announce its financial results for the ... May 5, 2008 at 5:00 p.m.,ET (2:00 p.m. ... 2008 earnings will,be distributed via PR Newswire and ...
... 22 United American Healthcare,Corporation (Nasdaq: UAHC ... Administration of the State of Tennessee, Bureau of ... new TennCare,contracts to two named organizations, not including ... ("UAHC Health Plan"), as,the culmination of TennCare,s selection ...
Cached Medicine News:Health News:The Future of Spine Care Has Just Gotten Better With the Use of SpineSix BioMotion Spinal System(TM) 2Health News:Court Throws Out Restraining Order Against SEIU 2Health News:Court Throws Out Restraining Order Against SEIU 3Health News:HIDA Welcomes the Introduction of Pedigree Reform Legislation and Urges Congressional Support for H.R. 5839 2Health News:drugstore.com, inc. to Announce First Quarter 2008 Results During Conference Call on Monday, May 5, 2008 at 5:00 p.m. ET 2Health News:United American Healthcare Corporation Provides Update on TennCare RFP Awards 2
...
...
... Severe revision options for the knee and ... modular system for the knee and hip ... that include surgical indication, implant selection, connection ... individual needs. This system addresses the needs ...
... The Natural-Knee family is a complete ... over 14 years of proven clinical ... innovative features including a proprietary CSTi ... in active patients, a unique bone-preserving ...
Medicine Products: